Iżrael - Ebrajk - Ministry of Health

abic marketing ltd, israel - prasugrel as hydrobromide - טבליות מצופות פילם - prasugrel as hydrobromide 5 mg - prasugrel

Iżrael - Ebrajk - Ministry of Health

sanofi israel ltd - metronidazole as benzoate - תרחיף - metronidazole as benzoate 25 mg/ml - metronidazole - metronidazole - infections caused by anaerobic bacterias, amebiosis, lambliasis and trichomonas.

Iżrael - Ebrajk - Ministry of Health

cts ltd - baclofen - תמיסה לאינפוזיה - baclofen 2 mg/ml - baclofen

Iżrael - Ebrajk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - טבליות מצופות פילם - eletriptan hydrobromide 24.242 mg - eletriptan

Iżrael - Ebrajk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - טבליות מצופות פילם - eletriptan hydrobromide 48.485 mg - eletriptan

Iżrael - Ebrajk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - טבליות מצופות פילם - eletriptan hydrobromide 96.97 mg - eletriptan

Iżrael - Ebrajk - Ministry of Health

cts ltd - baclofen - תמיסה לאינפוזיה - baclofen 0.5 mg / 1 ml - baclofen

Iżrael - Ebrajk - Ministry of Health

j-c health care ltd - bosentan as monohydrate - טבליות מצופות פילם - bosentan as monohydrate 62.5 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease

Iżrael - Ebrajk - Ministry of Health

j-c health care ltd - bosentan as monohydrate - טבליות מצופות פילם - bosentan as monohydrate 125 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease

Iżrael - Ebrajk - Ministry of Health

pfizer pharmaceuticals israel ltd - fesoterodine fumarate - טבליות עם שחרור מושהה - fesoterodine fumarate 4 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.